000 | 01544 a2200373 4500 | ||
---|---|---|---|
005 | 20250514015530.0 | ||
264 | 0 | _c20020212 | |
008 | 200202s 0 0 eng d | ||
022 | _a1058-4838 | ||
024 | 7 |
_a10.1086/322562 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEdwards, K M | |
245 | 0 | 0 |
_aDevelopment, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cDec 2001 |
||
300 |
_aS274-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Bacterial _xbiosynthesis |
650 | 0 | 4 |
_aBacterial Infections _xepidemiology |
650 | 0 | 4 | _aBlood Bactericidal Activity |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aHaemophilus Infections _xepidemiology |
650 | 0 | 4 | _aHeptavalent Pneumococcal Conjugate Vaccine |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 | _aImmunologic Memory |
650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPneumococcal Vaccines _ximmunology |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 |
_aVaccines, Combined _ximmunology |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 33 Suppl 4 _gp. S274-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/322562 _zAvailable from publisher's website |
999 |
_c11624565 _d11624565 |